Triazole-resistant Aspergillus fumigatus harbouring G54 mutation: Is it de novo or environmentally acquired?

Journal of Global Antimicrobial Resistance

Volumn 3, Issue 2, 2015, Pages 69-74

  Sharma, Cheshta ^a   Hagen, Ferry ^b   Moroti, Ruxandra ^c   Meis, Jacques F ^b,d   Chowdhary, Anuradha ^a  

^a UNIVERSITY OF DELHI   (India)

^b CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^c Matei Bals National Institute for Infectious Diseases   (Romania)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Environment; G54E mutation; India; Microsatellite typing; Romania; Tanzania; Triazole resistant A. fumigatus

Indexed keywords

BROMUCONAZOLE; CYPROCONAZOLE; DIFENOCONAZOLE; EPOXICONAZOLE; FUNGICIDE; HEXACONAZOLE; ISAVUCONAZOLE; ITRACONAZOLE; METCONAZOLE; PENCONAZOLE; POSACONAZOLE; TEBUCONAZOLE; TRIADIMEFON; TRIAZOLE; TRICYCLAZOLE; UNCLASSIFIED DRUG; VORICONAZOLE;

ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; ASPERGILLUS FUMIGATUS; FUNGAL GENE; FUNGAL STRAIN; FUNGUS ISOLATION; FUNGUS MUTATION; GENE TARGETING; GENETIC HETEROGENEITY; GENOTYPE; INDIA; LONG TERM EXPOSURE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; ROMANIA; SEQUENCE ANALYSIS; SOIL ANALYSIS; TANZANIA;

EID: 84929502653     PISSN: 22137165     EISSN: 22137173     Source Type: Journal    
DOI: 10.1016/j.jgar.2015.01.005     Document Type: Article

References (31)

1. D. Denning, A. Pleuvry, and D. Cole Global burden of allergic bronchopulmonary aspergillosis in adults with asthma and its complication chronic pulmonary aspergillosis in adults Med Mycol 51 2013 361 370
2. L. Alcazar-Fuoli, and E. Mellado Current status of antifungal resistance and its impact on clinical practice Br J Haematol 166 2014 471 484
3. J.W. van der Linden, E. Snelders, G.A. Kampinga, B.J. Rijnders, E. Mattsson, Y.J. Debets-Ossenkopp, and et al. Clinical implications of azole resistance in Aspergillus fumigatus, The Netherlands, 2007-2009 Emerg Infect Dis 17 2011 1846 1854
4. S.J. Howard, D. Cerar, M.J. Anderson, A. Albarrag, M.C. Fisher, A.C. Pasqualotto, and et al. Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure Emerg Infect Dis 15 2009 1068 1076
5. T.M. Diaz-Guerra, E. Mellado, M. Cuenca-Estrella, and J.L. Rodriguez-Tudela A point mutation in the 14α-sterol demethylase gene cyp51A contributes to itraconazole resistance in Aspergillus fumigatus Antimicrob Agents Chemother 47 2003 1120 1124
6. M.E. da Silva Ferreira, J.L. Capellaro, E. dos Reis Marques, I. Malavazi, D. Perlin, S. Park, and et al. In vitro evolution of itraconazole resistance in Aspergillus fumigatus involves multiple mechanisms of resistance Antimicrob Agents Chemother 48 2004 4405 4413
7. A. Chowdhary, S. Kathuria, J. Xu, and J.F. Meis Emergence of azole-resistant Aspergillus fumigatus strains due to agricultural azole use creates an increasing threat to human health PLoS Pathog 9 2013 e1003633
8. J. Chen, H. Li, R. Li, D. Bu, and Z. Wan Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma J Antimicrob Chemother 55 2005 31 37
9. M. Tashiro, K. Izumikawa, K. Hirano, S. Ide, T. Mihara, N. Hosogaya, and et al. Correlation between triazole treatment history and susceptibility in clinically isolated Aspergillus fumigatus Antimicrob Agents Chemother 56 2012 4870 4875
10. E. Snelders, R.A. Huis In't Veld, A.J. Rijs, G.H. Kema, W.J. Melchers, and P.E. Verweij Possible environmental origin of resistance of Aspergillus fumigatus to medical triazoles Appl Environ Microbiol 75 2009 4053 4057
11. M.J. Bromley, G. van Muijlwujk, M.G. Fraczek, G. Robson, P.E. Verweij, D.W. Denning, and et al. Occurrence of azole-resistant species of Aspergillus in the UK environment J Glob Antimicrob Resist 2 2014 276 279
12. 34/L98H mutations in the cyp51A gene in India PLoS ONE 7 2012 e52871
13. 34/L98H mutations in the cyp51A gene in Iran Mycoses 56 2013 659 663
14. 34/L98H mutations in outdoor and hospital environment in Kuwait Environ Res 133 2014 20 26
15. 46/Y121F/T289A mutation in India J Antimicrob Chemother 69 2014 555 557
16. A. Chowdhary, C. Sharma, M. van den Boom, J.B. Yntema, F. Hagen, P.E. Verweij, and et al. Multi-azole-resistant Aspergillus fumigatus in the environment in Tanzania J Antimicrob Chemother 69 2014 2979 2983
17. K.J. Kwon-Chung, and J.E. Bennett Medical mycology 1992 Lea & Febiger Philadelphia, PA 816
18. Clinical and Laboratory Standards Institute Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard - second edition. Document M38-A2 2008 CLSI Wayne, PA
19. E. Mellado, T.M. Diaz-Guerra, M. Cuenca-Estrella, and J.L. Rodriguez-Tudela Identification of two different 14-α sterol demethylase-related genes (cyp51A and cyp51B) in Aspergillus fumigatus and other Aspergillus species J Clin Microbiol 39 2001 2431 2438
20. A. Chowdhary, K. Agarwal, S. Kathuria, P.K. Singh, P. Roy, S.N. Gaur, and et al. Clinical significance of filamentous basidiomycetes illustrated by isolates of the novel opportunist Ceriporia lacerata from the human respiratory tract J Clin Microbiol 51 2013 585 590
21. T.A. Hall BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT Nucleic Acids Symp Ser 41 1999 95 98
22. C.H. Klaassen, H.A. de Valk, I.M. Curfs-Breuker, and J.F. Meis Novel mixed-format real-time PCR assay to detect mutations conferring resistance to triazoles in Aspergillus fumigatus and prevalence of multi-triazole resistance among clinical isolates in The Netherlands J Antimicrob Chemother 65 2010 901 905
23. H.A. de Valk, J.F. Meis, I.M. Curfs, K. Muehlethaler, J.W. Mouton, and C.H. Klaassen Use of a novel panel of nine short tandem repeats for exact and high-resolution fingerprinting of Aspergillus fumigatus isolates J Clin Microbiol 43 2005 4112 4120
24. P.A. Mann, R.M. Parmegiani, S.Q. Wei, C.A. Mendrick, X. Li, D. Loebenberg, and et al. Mutations in Aspergillus fumigatus resulting in reduced susceptibility to posaconazole appear to be restricted to a single amino acid in the cytochrome P450 14α-demethylase Antimicrob Agents Chemother 47 2003 577 581
25. J.L. Rodriguez-Tudela, L. Alcazar-Fuoli, E. Mellado, A. Alastruey-Izquierdo, A. Monzon, and M. Cuenca-Estrella Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus Antimicrob Agents Chemother 52 2008 2468 2472
26. S.M. Camps, J.W. van der Linden, Y. Li, E.J. Kuijper, J.T. van Dissel, P.E. Verweij, and et al. Rapid induction of multiple resistance mechanisms in Aspergillus fumigatus during azole therapy: a case study and review of the literature Antimicrob Agents Chemother 56 2012 10 16
27. P. Escribano, S. Recio, T. Peláez, M. González-Rivera, E. Bouza, and J. Guinea In vitro acquisition of secondary azole resistance in Aspergillus fumigatus isolates after prolonged exposure to itraconazole: presence of heteroresistant populations Antimicrob Agents Chemother 56 2012 174 178
28. E. Snelders, S.M. Camps, A. Karawajczyk, G. Schaftenaar, G.H. Kema, H.A. van der Lee, and et al. Triazole fungicides can induce cross-resistance to medical triazoles in Aspergillus fumigatus PLoS ONE 7 2012 e31801
29. A.M. Nascimento, G.H. Goldman, S. Park, S.A. Marras, G. Delmas, U. Oza, and et al. Multiple resistance mechanisms among Aspergillus fumigatus mutants with high-level resistance to itraconazole Antimicrob Agents Chemother 47 2003 1719 1726
30. E.G. Doukas, A.N. Markoglou, J.G. Vontas, and B.N. Ziogas Effect of DMI-resistance mechanisms on cross-resistance patterns, fitness parameters and aflatoxin production in Aspergillus parasiticus Speare Fungal Genet Biol 49 2012 792 801
31. A. Serfling, J. Wohlrab, and H.B. Deising Treatment of a clinically relevant plant-pathogenic fungus with an agricultural azole causes cross-resistance to medical azoles and potentiates caspofungin efficacy Antimicrob Agents Chemother 51 2007 3672 3676